Cognitive Analytic Therapy for Bipolar Disorder: A Pilot Randomized Controlled Trial by Evans, M. et al.
This is a repository copy of Cognitive Analytic Therapy for Bipolar Disorder: A Pilot 
Randomized Controlled Trial.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/110016/
Version: Accepted Version
Article:
Evans, M., Kellett, S., Heyland, S. et al. (2 more authors) (2016) Cognitive Analytic 
Therapy for Bipolar Disorder: A Pilot Randomized Controlled Trial. Clinical Psychology and
Psychotherapy. ISSN 1063-3995 
https://doi.org/10.1002/cpp.2065
This is the peer reviewed version of the following article: Evans, M. et al (2016) Cognitive 
Analytic Therapy for Bipolar Disorder: A Pilot Randomized Controlled Trial. Clin. Psychol. 
Psychother., which has been published in final form at https://doi.org/10.1002/cpp.2065. 
This article may be used for non-commercial purposes in accordance with Wiley Terms 
and Conditions for Self-Archiving.
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
Unless indicated otherwise, fulltext items are protected by copyright with all rights reserved. The copyright 
exception in section 29 of the Copyright, Designs and Patents Act 1988 allows the making of a single copy 
solely for the purpose of non-commercial research or private study within the limits of fair dealing. The 
publisher or other rights-holder may allow further reproduction and re-use of this version - refer to the White 
Rose Research Online record for this item. Where records identify the publisher as the copyright holder, 
users can verify any specific terms of use on the publisher’s website. 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
1 
Running head: CAT FOR BIPOLAR DISORDER 
 
 
Cognitive Analytic Therapy for Bipolar Disorder: 
A Pilot Randomized Controlled Trial     
 
Mark Evans  
Gaskell House Psychotherapy Centre, 
Manchester Mental Health and Social Care Trust, UK   
Stephen Kellett 
Sheffield Social and Health NHS Foundation Trust, UK 
Psychological Services Outcome Research Centre, University of Sheffield, UK   
Simon Heyland  
Specialist Psychotherapies Services, Devon House, Birmingham, UK 
Jo Hall 
University of Sheffield, UK  
& 
Shazmin Majid  
University of Sheffield, UK  
 
 
Correspondence  
Correspondence concerning this article should be addressed to Dr Mark Evans, Gaskell 
House Psychotherapy Centre, Swinton Grove, Manchester, M13 0EU.  
Email: Mark.Evans@mhsc.nhs.uk   
2 
 
The evidence base for treatment of bipolar affective disorder (BD) demands the evaluation of 
new psychotherapies in order to broaden patient choice.  This study reports on the feasibility, 
safety, helpfulness and effectiveness of cognitive analytic therapy (CAT).  In a pilot 
randomised controlled trial, BD patients in remission were randomised to either receiving 24 
sessions of CAT (N=9) or treatment as usual (N=9) and were assessed in terms of symptoms, 
functioning and service usage over time.  In the CAT arm no adverse events occurred, 8/9 
completed treatment, 5/8 attended all 24 sessions and 2/8 were categorised as recovered.  The 
most common helpful event during CAT was recognition of patterns in mood variability, 
with helpfulness themes changing according to phase of therapy.  No major differences were 
found when comparing the arms over time in terms of service usage or psychometric 
outcomes.   The study suggests that conducting further research into the effectiveness of CAT 
in treating BD is warranted and guidance regarding future trials is provided.   
 
Practitioner points:  
o Treating BD with CAT appears feasible and safe.      
o Retaining fidelity to the reformulation, recognition and revision structure of CAT 
appears useful.   
o Participants stated that across the phases of CAT, focussing on patterns of mood 
variability was consistently helpful.   
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In Bipolar Affective Disorder (BD) highly recurrent and episodic periods of mania 
(depending on the severity or whether there is psychosis) or hypomania and periods of 
profound depression predict clinically significant shifts in energy/activity levels that disrupt 
abilities to occupy and perform day-to-day roles and tasks (DSM-5; APA, 2013).  Bipolar I is 
characterized by an extreme manic or mixed episode and a major depressive episode and 
Bipolar II by one or more major depressive episodes and at least one episode of hypomania - 
with possible periods of euthymia between episodes.  Judd et al. (2005) noted that 
psychosocial disability in BD fluctuated in parallel with such changes in affective symptom 
severity.  Lifetime prevalence for BD is 1.3-1.6% and BD is equally common across the 
genders (NIMH, 2012).  Lithium (and other mood stabilising medications) persist as the 
pharmacological treatments of choice (Young & Hammond, 2007).  However, 
pharmacological adherence is problematic in 20-60% of cases (Adams & Scott, 2000), with 
high relapse rates, continuing difficulties and on-going psychosocial impairment common 
outcomes (Miklowitz & Scott, 2009).   
Judd et al. (2003) showed that BD patients also commonly suffer inter-episodic 
depressive symptoms even when medicated.  A recent review of cognitive impairments 
(Deglas et al. 2015) found that during acute phases, deficiencies were most commonly found 
in cognitive flexibility, with deficits in working memory typically occurring during remission 
phases.   Meta-analysis has shown that psychological therapies effectively augment 
pharmacology in reducing relapse rates (Scott, Colom & Vieta, 2007), with an associated 
recognition of the need to integrate psychotherapy into BD care-packages (Shannon & 
Swarbrick, 2010).  However, even in specialist Secondary Care services, less than one third 
of all BD cases receive any form of psychotherapy, highlighting high levels of unmet patient 
needs (Wittchen, Jacobi, Rehm, Gustavsson, Svensson, Jönsson, & Steinhausen, 2011) and 
also a lack of suitably trained therapists (Salcedo et al. 2016).     
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Psychological treatments of BD have evolved beyond early versions whose sole purpose 
centred on increasing medication adherence.  Contemporary psychological treatments for BD 
FDQEHFKDUDFWHULVHGE\WUHDWPHQWLQWHQVLW\$µORZLQWHQVLW\¶DSSURDFKWR%'LVGHILQHGE\
the delivery of a small number of brief sessions focussing on psychoeducation regarding 
treatment adherence, stress management, symptom awareness and substance abuse (Colom et 
DO   µ+LJK LQWHQVLW\¶ SV\FKRORJLFDO WKHUDSLHV DUH PRUH WUDGLWLRQDO DQG VR DGRSW D
formulation±driven treatment approach, with a greater number of longer sessions (Clark, 
Layard, Smithies, Richards, Suckling & Wright, 2009).  The evidence base for psychotherapy 
for BD reflects six main models (see Salcedo et al. 2016 for a review) which have been tested 
in clinical trials; psychoeducation (N=12 trials), cognitive behavioural therapy (N=9 trials), 
interpersonal and social rhythm therapy (N=2 trials), dialectical behaviour therapy (N=2 
trials), mindfulness based cognitive therapy (N=3 trials) and family therapy (N=3 trials).   
Outcomes can be negatively affected by comorbidity with other psychiatric disorders; the 
frequent comorbidity of personality disorder complicates the course of BD and also 
responsivity to treatment (Latalova, Pasko, Kamaradova & Ociskova, 2013). 
 A conclusion drawn from the Salcedo et al. (2016) review of empirically supported 
psychotherapies for BD was that patients may well be suited to differing interventions for BD 
and that associated matching and choice were clinically important. Given the extant evidence 
concerning inter-episodic residual symptoms (Judd et al. 2003), cognitive impairment 
(Deglas et al. 2015), comorbidity (Krishnan, 2005) and impaired functioning (Judd et al. 
2005), there is a need to develop and evaluate new applications of existing therapies (or 
develop bespoke therapies), in order to broaden access to effective therapies.  The recent Aas 
et al. (2016) systematic review noted that childhood trauma was a known risk factor for BD, 
in addition to trauma tending to generate more severe clinical presentation over time (e.g. 
earlier age at onset, increased risk of suicide and substance misuse). The role of interpersonal 
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relationships and self-concept is central to the ongoing management of BD (Goldberg & 
Harrow, 2005), with BD patients reporting significantly more interpersonal problems 
compared to community controls (Drieling, Scherer-Klabunde, Schaerer, Biedermann, Post 
& Langosch, 2010). Whilst interpersonal and social rhythm therapy has an interpersonal 
element (i.e. via emphasising the bidirectional nature of mood and interpersonal events), it 
does not make explicit use of the therapeutic relationship as a means of analysing (and 
changing) intra and interpersonal difficulties that are often related to childhood trauma.  
There is therefore a clear clinical need to trial a relational therapy for BD that can 
additionally formulate the role of childhood trauma.  The rationale for taking a more 
relational approach, is that if a therapy was able to facilitate changes in the relationship the 
BD patient has with themselves, the disorder and/or their broader interpersonal relationships, 
then the stress-diathesis model of BD (Scott, 2001) would state that this had the potential to 
change the dynamics of BD itself (or at least the manner in which the patient copes with the 
disorder).   
Cognitive analytic therapy (CAT) was developed in response to the need for short-term 
therapies in pressured public services (Ryle, 1995) and in the UK is a popular integrative 
therapy distinct in its explicit relational focus and methods (Ryle & Kerr, 2002).  The model 
has evolved from one for treating neurotic problems, to one which is typically used to treat 
complex and enduring mental health problems, particularly that of personality disorder in 
Secondary Care services (Ryle, Kellett, Hepple & Calvert, 2014).  For complex difficulties, a 
routine CAT contract consists of 24 weekly sessions plus four follow-ups (spaced over 6-
months)&DOYHUW	.HOOHWW¶s (2014) systematic review found that the CAT evidence base 
was generally founded on moderate to high quality outcome studies in typically complex 
clinical populations.   
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Theoretically, CAT draws on personal construct (Kelly, 1956) and object relations theory 
(Ryle, 1991).  Cognitive analytic theory asserts that negative mental representations of self, 
others and the world are developmentally formed by early neglectful or abusive interactions 
with significant others (Ryle & Kerr, 2002).  Such internalised, early object relations are 
termed reciprocal roles that influence how people anticipate, experience, enact and react to 
relational dynamics.  The theory also suggests that patients have learnt a repertoire of 
reciprocal roles and target problem procedures (TPPs; commonly referred to as traps, snags 
DQGGLOHPPDV5\OH	.HUUWRµVXUYLYH¶FKLOGKRRGDGYHUVLW\/trauma, but which are 
currently maladaptive (Clarke & Llewelyn, 1994).   
Clinically, CAT follows a three-phase process; (1) narrative and diagrammatic 
reformulation of the presenting problem to enable a shared understanding both of the 
developmental origins of difficulties and their current maintainers, (b) a recognition phase 
wherein the patient becomes more aware of their roles and procedures via self-monitoring 
and (c) a final revision phase in which change methods are collaboratively designed in order 
to change patterns and roles (Ryle, 1995).  Exits are the active change methods of CAT 
developed during the revision phase that support the patient in revising maladaptive 
procedures, with the therapist aiming to offer a containing, non-collusive experience 
throughout ± exits also include analysis of enactments of roles and procedures occurring 
within the therapeutic relationship (Bennett & Parry, 2004).  The change methods of CAT are 
catholic and can be drawn from any approach, as long as they are grounded in the 
reformulation of the patient (Kellett, 2012).    
The evolution of CAT for more complex presentations has been stimulated by the 
development of the multiple self-states model (MSSM; Ryle, 1995).  A self-state is defined 
by the presence of key affect, particular beliefs concerning self/others and the degree to 
which the patient is in touch with (and in control of) core feelings (Bedford, Davies & 
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Tibbles, 2009).  Theoretically, the MSSM conceptualises BD therefore as the lack of 
integration of a constellation of opposing/contrasting self-states and associated self-state 
switching (Kerr, 2001) which is captured in the diagrammatic reformulation.  Shannon and 
Swarbrick (2010) defined characteristic BD self-states as manic euphoria, controlled 
superiority, masked remission, critical shaming, psychotic anger, dismissing and rejected 
depression.  A typical CAT formulation of BD would therefore use the MSSM to reflect the 
hierarchical structure of both preferred (manic or hypomanic) and dreaded (depressed) self-
states, associated interpersonal status (e.g. in depression; losing, failing and impotent) and 
identity positions (e.g. in mania; winner, unique and special).  State switching is an 
involuntary strategy used to block out consciousness of unwanted information, which dictates 
the observable fixed/unhelpful reactions and responses (Elzinga, Phaf, Ardon & van Dyck, 
2003; Dalenberg et al. 2012).  As the MSSM captures both the manic and depressed elements 
of %')RXQWRXDNLV6KDQQRQ	6ZDUEULFNLWPHHWV&DVWOHHWDO¶V
demand for BD treatments to have the capacity to simultaneously formulate and treat both 
poles of BD.       
The evidence of CAT for BD is limited to one previous study.  Kerr (2001) reported a 
case series (N=4) of the application of CAT with treatment resistant hypomania with residual 
psychotic symptoms, in which two of the patients had a good qualitative outcome.  The study 
highlighted that the CAT model was useful in comprehending what was previously seen as 
µSV\FKRWLFSV\FKRSDWKRORJ\¶LQWHUPVRIWKH0660DQGWKDW&$7UHIRUPXODWLRn was both 
containing and also helped to reduce disturbed/non-compliant behaviours.  This current study 
sought to expand on this initial uncontrolled evidence; meta-analytic evidence of a weighted 
mean effect size across a variety of outcome measures of d+ = 0.83 for CAT (Ryle et al., 
2014) also provided an empirical foundation stone.   
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Medical Research Council (MRC) guidelines state that pilot trials are essential prior to 
any major trial seeking to evaluate a complex intervention such as psychotherapy (Lancaster 
et al. 2010).  The current study met the definition of an external pilot trial, as it was a stand-
alone pilot study (i.e. not the first stage of a larger trial), whose method included a 
randomisation procedure (Arnold, et al. 2009; Arain, Campbell, Cooper & Lancaster, 2010).  
The trial was also pragmatic because all participants were seen as an aspect of routine service 
delivery.  The primary aim was to provide preliminary evidence regarding the feasibility, 
safety, and helpfulness of CAT for BD, alongside testing the trial procedures themselves 
(recruitment, treatment, ability to follow-up patients and appropriateness of measures).  As 
the study also involved randomisation, a secondary aim was to compare outcomes (with 
treatment as usual).  The purpose was not to provide a definitive test of the efficacy of CAT 
for BD on an a priori specified primary outcome measure (Thabane et al. 2010).  This pilot 
rather sought to test the potential and feasibility of CAT with BD in preparation for a larger 
clinical trial and so providing some initial evidence of a new approach to treating BD in a 
frequently neglected population (Wittchen et al. 2011).  
 
Method 
Design and randomization  
The study design was a pragmatic randomized controlled trial, with BD patients randomised 
to either CAT or treatment as usual (TAU) within standard public sector care.  After initial 
diagnostic assessment, the psychiatrist undertaking the assessment communicated key 
assessment details to the trial coordinator.  Patient randomization to either arm of the trial 
was then completed by a computer-generated random allocation method undertaken by an 
independent body (School of Health and Related Research (ScHARR); Sheffield, UK).  A 
straight randomisation process was used (i.e. no feedback was given concerning 
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randomisation to the assessors.  If patients were allocated to CAT, the trial coordinator made 
direct contact with a study therapist who then offered therapy.  Psychometric outcomes were 
taken at four points in time; (1) pre CAT, (2) immediately post CAT, (3) at 6-months follow-
up and (4) at 12-months follow-up.  Patients in the TAU arm completed measures over a 
matched course of time.    
 
Sample and recruitment 
Potential participants had to have an extant clinical diagnosis of BD and also be under the 
care of psychiatric services.  Potential participants were recruited from community mental 
health teams within Manchester Mental Health and Social Care Trust in the UK and were 
treated within a specialist psychotherapy service.  The service offers various forms of 
evidenced based psychotherapies across a variety of diagnoses and BD would not normally 
routinely excluded.  The majority of the service¶s work concerns treatment of personality 
disorder.  Figure 1 illustrates that N=21 BD patients were referred and considered for 
eligibility; three of whom were excluded (2 declined to participate and 1 had a recent 
bereavement).  All patients referred to the trial underwent psychiatric assessment prior to 
randomisation to ensure Bipolar I or II diagnosis, via the Structured Clinical Interview for 
DSM Disorders (SCID-I; First, Williams, Spitzer & Gibbon, 2007).  This was also used to 
assess the rate of co-morbidities with other diagnoses.  The diagnostic assessments were 
completed by psychiatrists trained in SCID assessment for the purposes of the study.  
Assessing psychiatrists received supervision on each case prior to making definitive 
diagnostic decisions to ensure consistency - and also did not act as therapists within the trial.  
 Participants were excluded if they were exhibiting; (a) a current hypomanic or manic 
episode, (b) a current moderate or severe depressive episode, (c) current continuous and 
severe substance misuse, (d) poor command of English, (e) a learning disability, (f) current or 
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recent past (within 6 months) treatment of their BD with a formal psychotherapy or 
psychoeducative programme and finally (g) involvement in another psychological or 
pharmacological treatment trial and were in the follow up phase.  Patients who were in 
remission were chosen for the trial because, (1) this population has been studied in the early 
stages of testing other models, (2) as the focus of the trial was on feasibility, safety and 
effectiveness this meant that CAT sessions did not get used on the containment of acute 
episodes, (3) evidence from the Scott CBT trial found that psychological therapies were less 
efficacious when focussed on containing BD relapse (Scott et al. 2006) and (4) sub-
syndromal depressive symptoms are associated with significant impairment in BD (Judd et al. 
2005). 
Intervention; treatment as usual 
The control condition was TAU that included drug treatments (mood stabilizers, 
antidepressants and anti-psychotics) as recommended by NICE guidelines for BD (NICE, 
2006).  Participants in the TAU arm were therefore seen for regular outpatient treatment 
reviews with psychiatrists and had regular contact with community psychiatric nurses (CPN) 
acting as care coordinators.  Type and dose of medication was not recorded.  As TAU 
participants consented to not engaging in other psychological therapy during the trial, on 
completion of the study, all TAU patients were offered CAT.  Therefore, the control 
condition was a waitlist control (Elliott & Brown, 2002).    
Intervention; cognitive analytic therapy 
Participants in the experimental treatment arm of the trial received TAU, plus a course of 
CAT.  All therapies were delivered by Association of Cognitive Analytic Therapy (ACAT) 
accredited CAT practitioners and psychotherapists (N=5).  All therapists attended weekly 
individual clinical supervision for trial patients with an ACAT accredited supervisor and 
trainer.  Consistent with the CAT model for complex patients (Ryle & Kerr, 2002), treatment 
11 
 
consisted of 24 weekly fifty-minute one-to-one sessions, followed by four follow-up sessions 
(at one, two, three and six-months post-therapy).  CAT is delivered in three distinct stages: 
reformulation (sessions 0-6), recognition (sessions 6-12) and revision (sessions 12-24).  
During the reformulation stage, narrative and diagrammatic reformulations of BD were co-
constructed.  Narrative reformulations reformulated the experiences and traumas leaving 
patients prone to BD and were also used to predict potential alliance ruptures and anticipated 
unhelpful enactments within the therapeutic relationship (Ryle & Kerr, 2002).  Diagrammatic 
reformulations involved mapping of BD self-states and associated procedures, and are 
referred to as sequential diagrammatic reformulations (SDRs).  The recognition stage entailed 
self-monitoring of self-states and associated target problem procedures to improve awareness 
of reciprocal role relational dynamics (self-self; self-other; other-self) creating and 
maintaining BD self-states.  The final revision stage centred on change and entailed the 
FROODERUDWLYHGHYHORSPHQWRIµH[LWV¶ZKLFKZHUHODEHOOHGRQWKH6'5DQGSUDFWLVHGEHWZHHQ
sessions as homework (e.g. experimenting with being more behaviourally active when a 
mood decent cycle was recognised or analysis of an enactment within the therapeutic 
relationship).  All patients were invited to write an ending letter following CAT, to mirror the 
µJRRGE\HOHWWHU¶ZULWWHQby therapists.  Follow-up sessions entailed checking in on patient 
progress and reinforcing and revisiting the exits developed during therapy.        
Intervention; treatment fidelity 
CAT treatment fidelity was assessed via the Competence in Cognitive Analytic Therapy 
measure (CCAT; Bennett & Parry, 2004). The CCAT is a valid and reliable measure of CAT 
therapeutic competency.  The CCAT is scored across ten domains, with a global CCAT score 
=>20 being the cut-off score for competent CAT.  Each therapist in the trial had a CCAT 
completed on one of their treatment sessions, with treatment sessions chosen at random.  An 
accredited ACAT supervisor and trainer (independent of the research process) completed 
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CCAT ratings.  The mean CCAT score was 34.16 (SD = 5.49); all sessions sampled were 
above the competency cut-off score (Bennett & Parry, 2004).    
Outcome measures 
Researchers not involved in providing CAT or TAU and blind as to allocation collected 
primary and secondary measures.   
Primary outcome measures 
The primary outcome measures concerned feasibility, safety and helpfulness.  Feasibility of 
CAT was calculated via the mean number of CAT sessions attended and the treatment 
dropout rate.  Patient safety (Duggan et al. 2014) was monitored via adverse events 
monitoring in both arms of the trial on three indices; (1) crisis team involvement, (2) 
hospitalisation days and (3) a reliable deterioration on the CORE-OM (see measures section).  
Helpfulness of CAT was measured on responses to the Helpful Aspects of Therapy form 
which is a valid and reliable index of therapeutic helpfulness (Llewelyn, 1988).  The HAT 
asks participants (a) to describe the helpful or hindering event(s) that occurred in the session 
and (b) to rate the identified event(s) from 0 (hindering) to 9 (helpful).   
Secondary outcome measures 
The secondary measures comprised further indices of service utilisation and psychometric 
outcomes.  Service utilisation measures included: the number of psychiatry outpatient and 
community psychiatric nurse (CPN) appointments offered and attended.  For all service usage 
measures, comparisons were made between the 12-month period preceding entry into the 
study and the 12-month period immediately following therapy.  The following clinician and 
self-report valid and reliable psychometric outcome measures were administered: Beck 
Depression Inventory-II (BDI-II; Beck, Steer & Brown, 1995; a self-report measure of 
depression severity), Montgomery-Asberg Depression Rating Scale (MADRS; Montgomery 
& Asberg, 1979; a clinician report measure of the severity of depression for patients with 
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mood disorders), Bech-Rafaelson Mania Rating Scale (BRMRS; Bech et al. 1979; a clinician 
report assessment of current mania), Clinical Outcomes in Routine Evaluation ± Outcome 
Measure (CORE-OM; Evans et al. 2000; a self-report measure of psychological distress), 
Work and Social Adjustment Scale (WSAS; Mundt, Marks, Shear, & Greist, 2002; a self-
report measure of functioning) and Personality Structure Questionnaire (PSQ; Pollock et al. 
2001; a self-report measure of identity disturbance and state-shifting).  The PSQ is a CAT-
specific outcome measure derived from the MSSM, which has a caseness cut-off of 26-28 
(Berrios, Kellett, Fiorani & Poggioli, 2016) and is sensitive to change (Kellett, Bennett, Ryle, 
& Thake, 2013).     
Qualitative analyses  
Thematic analysis was conducted by SM on the qualitative descriptions of helpfulness events 
named on the HAT (Llewelyn, 1988) following CAT sessions.  Thematic analysis is a 
research method used to identify, analyse and report patterns/themes within qualitative data 
%R\DW]LV7KHDQDO\VLVZDVFDUULHGRXWIROORZLQJ%UDXQ	&ODUNH¶VSKDVH
approach to data analysis; (1) familiarisation with the helpfulness data in order to understand 
what was in the data and what was interesting about what was helpful, (2) development of 
initial codes to identify features of the helpfulness data that were relevant to the overall 
research question, paying particular attention to repetitive patterns or themes, (3) individual 
codes were then analysed to consider how they may be combined to form broader theme 
levels - at the end of this phase, a collection of helpfulness themes (and sub-themes) was 
created and all extracts of data were then coded in relation to these, (4) themes were then 
reviewed and refined to ensure thematic clarity and associated sharp distinctions between 
themes and finally, (5) naming of themes as a summary of the helpfulness thematic results.   
SM created and maintained a reflexivity journal to document close reflections on the 
helpfulness data.  The reflexivity journal was used to repeatedly review the qualitative 
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analysis during research supervision to reflect on emerging patterns, themes and concepts 
found in the helpfulness data.  The reflexivity diary also logged any concerns with the 
analysis, observations and parallels with the CAT theoretical framework and any issues with 
WKHFRGLQJSURFHVV(PHUVRQ)UHW]	6KDZ¶VUHFRPPHQGDWLRQVIRUFRGLQJILHOGZRUN
notes were used to draw particular attention to the following: (a) what were participants 
saying about specific helpful approaches or strategies in sessions and (b) how did participants 
describe and understand what had been helpful in the session?  SK acted as the outside 
reviewer of the reflexivity journal through evaluating the overall themes and in confirming 
the details of textual excerpts (Hosmer, 2008).  The final themes identified from the thematic 
analysis were then compared according to the different phases of CAT (i.e. reformulation, 
recognition and revision stages), in order to examine whether helpfulness themes changed 
according to phase of therapy.  Frequency counts of themes are used to illuminate which 
aspects of helpfulness were the most common according to which phase of therapy and HAT 
KHOSIXOQHVVVFRUHVDUHXVHGWRVKRZDµKHOSIXOQHVVUDWLQJ¶IRUHDFKWKHPH7KLVFUHDWHGD
mean and SD for each theme, in order to illustrate how helpful the theme was according to 
the reformulation, recognition and revision stages of CAT.   
Quantitative analyses 
Descriptive statistics are provided for CAT and TAU over time for both service usage and 
secondary outcome measures in order to compare outcomes.  Mann-Whitney U tests were 
used to compare service usage.  Treatment outcomes in the study arms on the secondary 
outcome measure were compared via repeated-measures ANOVAs on post-treatment and 
follow-up assessments (6 and 12-months).  In order to provide a conservative estimation of 
treatment effects, intention-to-treat analyses were conducted using the last observation 
carried forward method (LOCF; Carpenter & Kenward, 2008).  Post-hoc t-tests were then 
used to examine significant group-WLPHLQWHUDFWLRQV8QFRQWUROOHGHIIHFWVL]HV&RKHQ¶VG+) 
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were calculated for secondary outcome measures to demonstrate the size of the effect in each 
arm.  Effect sizes were calculated using the follow-up change score during CAT divided by 
the pre-intervention SD (Westbrook & Kirk, 2005).  Between-group effect size comparisons 
were achieved by dividing the difference between TAU and CAT outcomes post-therapy (or 
at follow-XSE\WKHSRROHGVWDQGDUGGHYLDWLRQ(IIHFWVL]HVZHUHFRQVLGHUHGZLWK&RKHQ¶V
(1992) power primer that denotes d+  DVD³VPDOO´HIIHFt, d+  DVD³PHGLXP´HIIHFW
d+  DVD³ODUJH´HIIHFW7KHGHJUHHRISV\FKRORJLFDOFKDQJHDFKLHYHGGXULQJ&$7ZDV
then categorised on the CORE-OM using the reliable change index (RCI; Jacobson & Truax, 
1991).  Reliable and clinically significant change is increasingly taken as a credible index of 
psychological recovery (Barkham, Stiles, Connell & Mellor-Clark, 2012).  Clinically 
significant change was deemed to have occurred when the pre-post CORE-OM score reduced 
from the clinical (>10 score) to a non-clinical (<10 score) population (Evans, Margison & 
Barkham, 1998).  In accordance with extant RCI recommendations (Evans et al. 1998), 
UHOLDEOHLPSURYHPHQWZDVUHFRUGHGZKHQDQLQGLYLGXDOSDWLHQW¶VSUH-post score on the 
CORE-OM improved by equal to or more than 1.96 times the SEdiff; a reliable change index 
of 5 was therefore adopted (Connell et al., 2007).   
 
Results  
 
Treatment feasibility   
Figure 1 displays the entry of patients into the trial (organised according to CONSORT 
recommendations; Moher et al., 2001), showing that eighteen patients were randomised to 
either CAT or TAU. All randomized patients were subsequently analysed using an intention-
to-treat approach.  The CAT group consisted of 7 females and 2 males with an average age of 
48.33 (sd = 9.84) years; 8 of the CAT participants had a BD1 diagnosis and 1 had a BD2 
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diagnosis and all were prescribed medication.  The TAU arm consisted of 7 females and 2 
males, with in average age of 45.66 (sd = 12.55) years; 8 of the TAU participants had a BD1 
diagnosis and 1 had a BD2 diagnosis and all were prescribed medication.  There were no 
significant differences in terms of age (p = .62) or gender distribution (p = .72) between the 
two arms of the trial.  Co-morbidity was common; 4/9 (44.4%) of CAT patients and 6/9 
(65.2%) of TAU patients met diagnostic criteria for at least one other psychiatric diagnosis, 
but there was no difference in the rate of psychiatric comorbidities (p = .14) between the 
arms.  In the CAT arm, nine patients started therapy, with one participant transferred to a 
different service after 7-months, due to relocating.  In the TAU arm, four patients dropped 
out of the study.  Two patients in both arms were lost to follow-up.  In the CAT arm, 8/9 
patients completed full treatment (treatment completion rate = 88.8%).  In terms of sessional 
attendance, 5/8 (62.5%) patients attended every one of their 24 CAT sessions - the median 
and mean number of CAT sessions attended was 22 (91.66% of sessions attended), with a 
mode of 24 sessions attended.  
 
Insert figure 1 here please 
 
 
Treatment helpfulness  
Thematic analysis of HAT forms for CAT patients identified seven themes; (1) recognition of 
mood variability, (2) the experience of narrative feedback, (3) building and use of SDRs, (4) 
identifying exits, (5) psychotherapeutic support, (6) recognition of progress and (7) 
uneventful session.  Table 2 contains textual excerpts in order to illuminate the theme 
identified.  The frequency of helpful event themes and also the mean helpfulness ratings for 
each theme across the reformulation, recognition and revision phases of CAT are reported in 
Table 3.  Results illustrate that uneventful sessions were an infrequent occurrence regardless 
of phase and ratings of helpful events were typically high.   
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During the reformulation stage of CAT, the most commonly occurring helpful event 
was when therapists helped patients to recognize patterns in their mood variability (event n = 
24).  This continued to be a common helpful event across recognition (event n = 7) and 
revision (event n = 16) phases.  Co-construction of SDRs generated the highest mean 
helpfulness score (8.50) during the reformulation phase.  During the recognition stage of 
CAT, the most frequent helping events were when patients were able to recognise the initial 
progress being made within therapy and also to start on generating exits (event n=13).  Again, 
use of SDRs generated the highest helpfulness ratings during the recognition phase.  
Consistent with the model, an increase in exit work was evidenced over the phases, with the 
highest frequency of exit work taking place in the final revision stage (event n =17).  This 
increase in helpful exit events is mirrored by active use of the SDR also being a frequent 
event in the final revision phase (event n = 14)7KHµH[SHULHQFHRIQDUUDWLYHIHHGEDFN¶
theme covered the reformulation letter during the early stages of the therapy (event n =5) and 
the goodbye letter delivered at termination of the revision stage (event n =5).   
 
Insert tables 1 and 2 here 
 
Treatment safety  
Descriptive statistics for adverse events and service usage for CAT and TAU are presented in 
Table 3.  When the 12-month period preceding entry into the study was compared to the 12-
month period immediately following therapy, no differences in service usage or adverse 
events (hospitalization; 1 participant in each arm) were apparent.  No single patient in the 
CAT and one patient in the TAU arm were seen by the crisis team.   
 
Insert table 3 here 
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Treatment effectiveness  
Table 4 contains mean scores, effect sizes and within and between group comparisons on the 
secondary outcome measures at baseline, end of treatment, 6 and 12-months follow-up.  End 
of treatment effect sizes (d+) in the CAT group were generally medium sized, whilst for TAU 
effect sizes (d+) were generally small.  End of treatment between-group effect size estimates 
generally indicated small treatment effects in favour of CAT.  At 6 and 12-month follow-up, 
treatment effects generally demonstrated equivalence of outcomes.   However, on the PSQ at 
6-month follow-up there was a medium between-group effect size favouring CAT.  The 
repeated-measures ANOVAs found that for both CAT and TAU significant improvements on 
secondary outcomes occurred over time (as measured by the BDI, CORE-OM and PSQ). 
Time x group interactions were non-significant for all outcome measures, across all 
measurement points, indicating no significant differences in treatment outcomes between 
CAT and TAU.  Again, an exception to this was found regarding PSQ scores at 6-months 
follow-up; a significant interaction of time and group was observed.  However, a post-hoc 
two-tailed t-test did not indicate that CAT resulted in significantly larger PSQ treatment 
effects than TAU at 6-month follow-up (t = 1.25, df = 16, p = 0.23).  Figure 2 provides a 
visual representation of pre-post CORE-OM outcomes for both arm of the trial.  Two CAT 
participants demonstrated clinically significant and reliable change (i.e. scoring beneath the 
cut-off line and also outside the no change tramline) and were therefore classified as 
µrecovered¶ post-treatment.  No TAU participants met the criteria for recovery. The majority 
of CAT (n = 6) and TAU (n =7) participants, KDGDµVWDVLV¶RXWFRPHLH
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no change tramlines).  No participants (TAU or CAT) had a reliable deterioration in 
psychological distress.   
 
Insert table 4 and figure 2 here 
Discussion  
This study reported findings from the first pilot trial of CAT for BD and so makes a 
contribution by (a) showing that CAT is a safe, feasible and helpful form of psychological 
therapy for BD in routine care and (b) by adding to the emerging CAT evidence base (Calvert 
& Kellett, 2014).  The value of pilot trials is widely recognised (Whitehead, Sully & 
Campbell, 2014), particularly so in difficult-to-treat conditions such as BD and also when the 
treatment being tested is anticipated to be complicated to deliver and/or to engage with.  In 
terms of feasibility evidence, results suggest that participants found CAT to be engaging as 
high numbers of sessions were attended and also treatment contracts were typically 
completed.  There was also preliminary evidence of CAT being a safe intervention for BD, as 
the service usage outcomes were similar to TAU and no patients in the CAT arm had a 
reliable deterioration in psychological distress during treatment (Duggan et al. 2014).  The 
trial procedures themselves did not highlight any major issues (e.g. during recruitment or in 
terms of outcome measures).  Analysis of the secondary outcome measures suggested few 
stark differences between the arms, but a trend for a moderate effect in CAT and a small 
effect in TAU.  In both arms of the trial comorbidity was common; strong associations are 
common between BD and substance abuse, cyclothymia, anxiety, personality disorders, 
ADHD and also eating disorders (Krishnan, 2005).       
Treatment feasibility is multifaceted (Tickle-Degnen, 2013), but an important aspect 
is whether SDWLHQW¶V can and do complete treatment.  The feasibility of providing CAT to BD 
patients was evidenced by the high average sessional attendance rate (over 90 %) and the low 
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treatment dropout rate (12.2%).  5/8 CAT participants attended every session offered in the 
contract, suggesting sustained therapeutic engagement.  Treatment completion has previously 
been found to be an important predictor of outcome (Cahill et al. 2003).  BD patients are 
often characterised as often difficult to engage in psychological treatment (Basco & Rush, 
2005) and so the attendance findings for CAT are encouraging.   
Another aspect of feasibility is the patient experience of the therapy (Tickle-Degnen, 
2013).  In order to assess the helpfulness of CAT for BD in greater detail, a thematic analysis 
was completed on named helpful events in HAT forms, with six helpfulness themes emerging 
(with one theme of uneventful sessions).  Across the three phases, the theme of CAT helping 
patients to recognize patterns within their mood variability was a consistent finding.  Part of 
WKHUHFRJQLWLRQSKDVHRI&$7HQWDLOVHQDEOLQJSDWLHQWVWRRFFXS\DQµREVHUYLQJH\H¶SRVLWLRQ
from which they can notice previously automatic or stereotyped relational patterns (Ryle & 
Kerr, 2002).  This is based on the object relations procedural sequence approach (Ryle, 1991) 
and encourages CAT therapists to name and map patterns of thoughts, feelings and behaviour 
HPHUJLQJIURPUHFLSURFDOUROHV7KLVDOORZVSDWLHQWVWRµVWDQGEDFN¶DQGUHFRJQLVHZKHQ
patterns or role positions are about to happen, are happening or have just happened.  Within 
treatment of BD, this CAT approach seemed helpful to patients in recognising the patterns 
reliably creating shifts in their mood states.  The helpfulness results would reflect the CAT 
clinical method; engage the patient in rapid reformulation of the self-states and procedural 
patterns of their BD as the foundation stone upon which enhanced recognition can then 
IDFLOLWDWHµH[LWZRUN¶Finally, in terms of feasibility, the Salcedo et al. (2016) review noted 
the dilemma of the availability of empirically-supported treatments for BD, but the lack of 
suitably qualified therapists to provide them.  All therapists in the current trial were qualified 
WRWKHOHYHORIDWOHDVWDµ&$7SUDFWLWLRQHU¶ZKLFKHQWDLOVD-year therapy qualification (8 
closely supervised cases and associated coursework) as an addition to a core therapy training 
21 
 
in another modality.  Attempting to deliver CAT for BD would be unwise without 
appropriate training and supervision, whilst there needs not to be a bottle-neck of provision, 
due to a lack of appropriately qualified therapists. 
The outcome comparison between CAT and TAU highlighted some intriguing 
differences in terms of PSQ outcomes (Pollock et al. 2001).  At 6-month follow-up there was 
a medium between-group effect size favouring CAT with a significant time x group 
interaction (tempered by a subsequent non-significant t-test).  The PSQ is a measure of 
identity confusion/state-switching theoretically grounded in the MSSM (Berrios et al. 2016) 
and results suggest that CAT patients at follow up were reporting less state-switching.  This 
finding would encourage both the use of the MSSM to conceptualise BD and also the need to 
consider the PSQ as the primary outcome measure in future trials of CAT for BD.  On the 
CORE-OM two of the CAT participants achieved µUHFRYHU\¶VWDWXVRQWKH&25(-OM, 
suggesting a marked individual change in psychological distress not apparent for any single 
participant in TAU.  The within group changes on the secondary outcome measures apparent 
in the TAU arm may have been due to engagement in the research process itself (Godin, 
Germain, Conner, Sheeran & Delage, 2012) and there is meta-analytic evidence that wait-
times in wait-list control trials are associated with improvement (Hesser et al. 2011).  It is 
noticeable that the changes that did occur were found solely on the self-report measures.  
This may reflect that the participants felt that change had occurred, but assessors did not 
share in this opinion.  Indeed, meta-analytic evidence notes that clinician-rated and self-
report outcomes measures for depression are non-equivalent and that different symptoms are 
better suited to one or the other, and so clinical trials should include both (Cuijpers, Li, 
Hoffman & Andersson, 2010).  The lack of change in manic and depressive symptoms in the 
current study may have been due to the participant sample being drawn from patients 
currently in remission.          
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In terms of methodological weaknesses and future directions, the small number of 
participants randomized to the study arms (and also subsequent unequal attrition within the 
arms) is certainly the most critical.  Whilst the sample size was appropriate for the pilot 
nature of the study (Julious, 2005), larger samples would be needed in future studies to detect 
consistent significant differences in outcome between study arms and also compare cost and 
health economic outcomes.  The factors creating stasis outcomes are worthy of examination 
(Kellett, Webb, Wilkinson, Bliss & Hardy, 2016).  Personality disorder co-morbidity would 
be an important covariate in the analysis of future studies (Latalova, Pasko, Kamaradova & 
Ociskova, 2013) and stringent assessment of comorbid physical and psychological disorders 
is indicated (Krisnan, 2005).  Furthermore, the rate of previous BD episodes, impulsivity 
(Etain et al. 2013), childhood adversity (Aas et al. 2016) and type and dosage of current 
pharmacology should be recorded in future trials.   Extensive trial selection criteria were 
employed which reduces the generalisability of the current findings (Rothwell, 2006).  The 
follow-up period could have been longer to more effectively index long-term outcomes.  The 
CCAT data were restricted to one session per therapist and therefore wider CCAT analysis 
(e.g. one session per phase of CAT per patient) would have been preferable.  Although CAT 
WKHRU\GLFWDWHVDµWKUHH-SKDVHDSSURDFK¶DQGWKHKHOSIXOQHVVGDWDZHUHDQDO\VHGDFFRUGLQJO\
in clinical practice there is often overlap between phases.  Because in the current study the 
participants randomised to CAT received greater amounts of care (by dint of attending for 
therapy), then future trials need to compare CAT with another active psychological treatment 
(in medicated participants) to equalise the amount of care in the arms.  In terms of supporting 
patient choice, a patient-preference randomised control trial (Howard & Thornicroft, 2006) 
would be the ultimate test of treatment acceptability between the psychotherapies for BD.       
In conclusion, this study reported outcomes the first pragmatic pilot trial of CAT for 
BD with findings providing initial evidence of feasibility, subjective helpfulness and safety.  
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The CAT effect size results (although admittedly preliminary due to the small sample size) 
are encouraging.  Results imply that future CAT studies with BD would not suffer from 
issues with recruitment.  Patients were also willing to be randomised, but future studies need 
to develop effective mechanisms to reduce dropout rates (Oldham, Kellett, Miles & Sheeran, 
2012) and also capture long-term follow-up outcomes.  CAT specific factors such as early 
collaborative narrative and diagrammatic reformulation were found to be most helpful which 
mirrors the early Kerr (2001) BD evidence'.  Whitehead et al. (2014) stated that pilot trials 
should determine whether a clinically meaningful effect has taken place.  The authors 
propose that this has been found here for CAT for BD and so this pilot study functions as a 
foundation stone upon which future properly powered and controlled studies can now be 
conducted.   
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Table 1. Themes and quotes from the Helpful Aspects of Therapy measure 
Theme CAT participant quote 
Recognition of patterns of mood 
variability  
µ,WZDVPHQWLRQHGWKDW,QHHGWRUHFRJQLVHP\
PRRGDQGLWKHOSHGPHDELW¶ 
µ6HHLQJDQGEHLQJDOORZHGWRH[SUHVVfeelings of 
ZDQWLQJWRFRPPLWVXLFLGHZKHQGHSUHVVHG¶ 
µ'HVFULELQJWKHGLIIHUHQFHVEHWZHHQDEDGGD\DQG
GHSUHVVLRQ¶  
µTo really start to pick apart the whole area of 
suicidal self-harming thoughts/impulses of my 
LOOQHVV¶ 
Experience of narrative reformulation µ7KHUDSLVWZULWLQJPHWKHOHWWHUDERXWDOOZH¶YH
WDONHGDERXW¶ 
µ7HDVLQJRXWP\PRWKHUDQGIDWKHUVLQGLYLGXDO
characters and the relationships I have with them 
DVDUHVXOW¶ 
µ)URPOLVWHQLQJWRZKDW,ZDVVD\LQJDQGWKH
therapist reflecting back in the letter, I came to 
UHDOLVH,¶GPRYHGTXLWHTXLFNO\LQWKLVDWWHPSWHG
TXHVWIRUSURPRWLRQ¶ 
µ7KHUDSLVWZULWLQJPHWKHOHWWHUDERXWDOOZH¶YH
WDONHGDERXW¶ 
µIt picked up the hardness of facing re-building my 
OLIH¶ 
Building and use of SDR µ7KHUDSLVW making me recognise some things about 
P\VHOIDQGKRZ,DPLQUHODWLRQVKLSVRQWKHPDS¶ 
µ7DONLQJDERXWP\VWRU\DQGGUDZLQJDPDSRIP\
WKRXJKWV¶ 
µ0DSRIWKRXJKWV¶ 
Identifying exits µ)RXQGDQH[LW¶ 
µ)LQGLQJH[LWV¶ 
µ7DONLQJDERXWH[LWV¶  
µFinding exit IRUIUR]HQ¶ 
Psychotherapeutic support µ-XVWWDONLQJZLWKQRKROGLQJEDFNDQGLQ
confidence, about things I would never speak 
DERXW¶ 
µ7KHPRVWLPSRUWDQWWKLQJZDVPHDFWXDOO\
attending, when it was the last thing I wanted to 
GR¶ 
µ7KHUDSLVWUHVSRQGHGWLPHOy to my request for help 
IRUDSKRELDRIZDVSV¶ 
µ6RPHWKLQJWKHUDSLVWVDLGDVNHGWULJJHUHGDYHU\
rapid mood change from confident and buoyant to 
slightly fearful and sad. Therapist responded 
immediately showing he had noticed it and was 
YHU\HPSDWKHWLF¶ 
Recognition of progress  µ/RRNHGDWLPSURYHPHQWV,KDGPDGHLHGRLQJ
39 
 
OHVVSODQQLQJ¶ 
µ7REHUHPLQGHGWKDW,DPGRLQJZHOO¶ 
µ7DONLQJDERXWGRLQJZHOO¶ 
Uneventful session µ1RWKLQJHYHQWIXO¶ 
µ1RWKLQJWRGD\UHDOO\¶ 
µ,QWKLVVHVVLRQ,ZDVLQDYHU\ORZmood so 
explained this to therapist.  For this reason, I have 
nothing to say on the form today and feel it 
QHFHVVDU\WRH[SODLQWKLV¶ 
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Table 2. Frequency (count) and degree (HAT mean and SD) of helpfulness during CAT for BD    
 
Theme Reformulation Phase Recognition Phase Revision Phase 
Count Mean SD Count Mean SD Count Mean SD 
Recognition of patterns 
of mood variability  
24 8.05 1.05 7 7.75 0.97 16 8.70 0.47 
Experience of narrative 
reformulation 
5 7.66 0.57 3 8.00 0.00 5 8.75 0.50 
Building and use of 
SDR 
4 8.50 0.57 6 8.83 0.40 14 8.23 1.23 
Identifying exits  11 7.84 0.80 13 7.85 0.89 17 7.73 1.40 
Psychotherapeutic 
support 
3 7.75 0.95 5 8.50 0.54 8 7.62 1.59 
Recognition of progress  0 0 0.00 13 8.10 0.99 11 8.63 0.67 
Uneventful session 4 - - 2 - - 3 - - 
1 
Table 3. Adverse event and service usage  
 
 
 
 
 
 
Measure of service usage  
 
CAT  
(N = 9) 
 
TAU  
(N = 9) 
 
CAT vs. 
TAU 
 
 
 
M 
 
 
 
SD 
 
 
 
M 
 
 
 
SD 
Comparing 
pre-post 
changea  
U (p)  
Number of clinic appointments attended      
  Pre-treatment 4.00 3.46 3.66 2.34  
  Post-treatment 3.33 2.34 3.33 2.95 34.50 (.61)  
Number of clinic appointments missed      
  Pre-treatment 0.44 0.73 0.33 0.50  
  Post-treatment 0.33 0.70 0.33 0.50 39.00 (.93) 
CPN appointments attended      
  Pre-treatment 12.00 13.10 8.22 11.44  
  Post-treatment 11.00 13.72 25.2 39.95 33.50 (.55) 
CPN appointments missed       
  Pre-treatment 0.55 1.01 0.22 0.44  
  Post-treatment 0.55 0.88 1.22 1.78 35.00 (.67) 
Number of inpatient admissions      
  Pre-treatment 0.11 0.33 0.11 0.33  
  Post-treatment 0.00 0.00 0.11 0.33 40.50 (1.0) 
Number of inpatient days      
  Pre-treatment 2.88 8.66 27.66 83.00  
  Post-treatment 0.00 0.00 6.55 19.66 40.00 (1.0) 
Number of CHRT admissions      
  Pre-treatment 0.00 0.00 0.33 0.70  
  Post-treatment 0.00 0.00 0.11 0.22 31.50 (.44) 
Number of CHRT days      
  Pre-treatment 0.00 0.00 2.66 7.63  
  Post-treatment 0.00 0.00 0.77 2.33 31.50 (.44) 
a between-group comparison of pre to post-treatment change scores (CAT vs. TAU). 
CPN = community psychiatric nurse, CHRT = crisis resolution home treatment. 
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Table 4. Secondary outcome measure analyses  
  
 
Within-group outcomes and analyses 
 
Between-group analyses 
(CAT vs. TAU) 
  
 
CAT (N = 9) 
 
 
TAU (N = 9) 
  
Repeated-measures 
ANOVAs (F) 
 
Variable 
and time 
Point 
 
 
 
M 
 
 
 
SD 
 
 
 
ES 
 
 
 
M 
 
 
 
SD 
 
 
 
ES 
 
Between
-group 
ES 
 
 
 
Timec 
 
 
Time x 
treatmentd 
BDI          
   BL 29.00 14.92  28.44 14.77     
   EOT 19.33 17.58 0.65 23.78 14.58 0.32 0.28 7.86* 0.96 
   6-FU 24.00 18.30 0.34 24.89 15.40 0.24 0.05 5.51* 0.16 
   12-FU 20.67 20.77 0.56 21.22 17.48 0.49 0.03 7.31* 0.40 
MADRS          
   BL 13.33 8.30  13.77 6.96     
   EOT 13.77 12.27 -0.05 12.66 9.27 0.16 -0.06 0.24 0.96 
   6-FU 12.89 10.87 0.05 13.56 11.57 0.03 0.06 0.03   0.003 
   12-FU 13.78 12.27 -0.05 11.78 10.46 0.29 -0.18 0.15 0.36 
BRMRS          
   BL 0.44 0.88  0.00 0.00     
   EOT 0.00 0.00 0.50 0.22 0.66 - 0.47 0.36 3.27 
   6-FU 0.00 0.00 0.50 0.00 0.00 - 0.00 2.29 2.29 
   12-FU 0.00 0.00 0.50 0.00 0.00 - 0.00 2.29 2.29 
CORE-OM          
   BL 17.88 7.88  19.33 8.70     
   EOT 14.33 8.73 0.55 16.33 9.57 0.34 0.22  9.72** 0.07 
   6-FU 15.00 9.54 0.37 15.22 9.60 0.47 0.02  9.70** 0.30 
   12-FU 13.33 10.72 0.58 15.66 9.78 0.42 0.23 8.08* 0.09 
WASA          
   BL 28.78 10.87  27.78 12.50     
   EOT 24.44 14.00 0.40 26.78 10.66 0.08 0.19 1.18 0.69 
   6-FU 23.44 13.94 0.49 25.00 11.79 0.22 0.12 4.38 0.44 
   12-FU 23.67 12.65 0.47 23.33 14.11 0.36 0.03 3.17 0.02 
PSQ          
   BL 28.22 6.96  27.44 5.55     
   EOT 22.56 9.35 0.81 26.22 5.82 0.22 0.47 8.43* 3.51 
   6-FU 22.00 11.43 0.89 27.33 5.72 0.02 0.59 7.14*   6.65* 
   12-FU 25.00 8.38 0.46 26.44 5.73 0.18 0.20 3.51 0.97 
Note. *p <.05; **p <.01; ***p <.001. 
ES = effect size estimate, SD = standard deviation, - = not possible to calculate, BL = 
baseline, EOT = end of treatment, 6-FU = 6-months follow-up, 12-FU = 12-months  
follow-up. a Within-group effect size estimates calculated as pre-treatment mean minus the 
post-treatment mean, divided by the pre-treatment standard deviation.b Between-group effect 
size estimates calculated as the post-treatment TAU mean, minus the post-treatment CAT 
mean, divided by the pooled post-treatment standard deviation.c, d (df = 1, 16).  
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Figure 2. Plot of pre-post CORE-OM outcomes in the arms of the trial.  
 
